KR100371981B1 - 치환된알킬디아민유도체,이의제조방법및이를포함하는약제학적조성물 - Google Patents

치환된알킬디아민유도체,이의제조방법및이를포함하는약제학적조성물 Download PDF

Info

Publication number
KR100371981B1
KR100371981B1 KR1019960707303A KR19960707303A KR100371981B1 KR 100371981 B1 KR100371981 B1 KR 100371981B1 KR 1019960707303 A KR1019960707303 A KR 1019960707303A KR 19960707303 A KR19960707303 A KR 19960707303A KR 100371981 B1 KR100371981 B1 KR 100371981B1
Authority
KR
South Korea
Prior art keywords
ethylamino
methyl
compound
formula
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019960707303A
Other languages
English (en)
Korean (ko)
Inventor
티모시 피 버크홀더
엘리자베쓰 쿠들락츠
티우-빈 리
Original Assignee
메렐 파마슈티칼스 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 메렐 파마슈티칼스 인크. filed Critical 메렐 파마슈티칼스 인크.
Application granted granted Critical
Publication of KR100371981B1 publication Critical patent/KR100371981B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/78—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/52—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the nitrogen atom of at least one of the carboxamide groups further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
KR1019960707303A 1994-06-20 1995-05-19 치환된알킬디아민유도체,이의제조방법및이를포함하는약제학적조성물 Expired - Fee Related KR100371981B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/262,209 US5597845A (en) 1994-06-20 1994-06-20 Substituted alkyldiamine derivatives
US08/262,209 1994-06-20

Publications (1)

Publication Number Publication Date
KR100371981B1 true KR100371981B1 (ko) 2003-06-12

Family

ID=22996631

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019960707303A Expired - Fee Related KR100371981B1 (ko) 1994-06-20 1995-05-19 치환된알킬디아민유도체,이의제조방법및이를포함하는약제학적조성물

Country Status (20)

Country Link
US (1) US5597845A (cg-RX-API-DMAC7.html)
EP (1) EP0767783B1 (cg-RX-API-DMAC7.html)
JP (1) JP3920916B2 (cg-RX-API-DMAC7.html)
KR (1) KR100371981B1 (cg-RX-API-DMAC7.html)
CN (1) CN1083429C (cg-RX-API-DMAC7.html)
AT (1) ATE169905T1 (cg-RX-API-DMAC7.html)
AU (1) AU691619B2 (cg-RX-API-DMAC7.html)
CA (1) CA2193348C (cg-RX-API-DMAC7.html)
DE (1) DE69504198T2 (cg-RX-API-DMAC7.html)
DK (1) DK0767783T3 (cg-RX-API-DMAC7.html)
ES (1) ES2121389T3 (cg-RX-API-DMAC7.html)
FI (1) FI115135B (cg-RX-API-DMAC7.html)
HU (1) HUT75965A (cg-RX-API-DMAC7.html)
IL (1) IL114185A (cg-RX-API-DMAC7.html)
MX (1) MX9606654A (cg-RX-API-DMAC7.html)
NO (1) NO307458B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ287291A (cg-RX-API-DMAC7.html)
TW (1) TW442451B (cg-RX-API-DMAC7.html)
WO (1) WO1995035279A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA954947B (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW541295B (en) * 1999-01-05 2003-07-11 Nippon Zoki Pharmaceutical Co A novel substituted alkylteraamine derivative for use as tachykinin antagonist
US6613801B2 (en) * 2000-05-30 2003-09-02 Transtech Pharma, Inc. Method for the synthesis of compounds of formula I and their uses thereof
JP2004523565A (ja) 2001-03-05 2004-08-05 トランス　テック　ファーマ，インコーポレイテッド 治療因子としてのベンゾイミダゾール誘導体
CN1494425B (zh) 2001-03-05 2011-12-07 特兰斯泰克制药公司 用作治疗剂的羧酰胺衍生物
ATE529110T1 (de) 2002-03-05 2011-11-15 Transtech Pharma Inc Mono- und bicyclische azolderivate die die interaktion von liganden mit rage hemmen
US20090263370A1 (en) * 2006-11-30 2009-10-22 Guoliang Tao Methods for treating tachykinin-mediated diseases with cholinesterase
TWI517850B (zh) 2009-09-30 2016-01-21 Ｖｔｖ治療有限責任公司 經取代之咪唑衍生物及其使用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164372A (en) * 1989-04-28 1992-11-17 Fujisawa Pharmaceutical Company, Ltd. Peptide compounds having substance p antagonism, processes for preparation thereof and pharmaceutical composition comprising the same
WO1994004494A1 (en) * 1992-08-13 1994-03-03 Warner-Lambert Company Tachykinin antagonists
EP0593559A1 (en) * 1991-07-05 1994-04-27 MERCK SHARP & DOHME LTD. Aromatic compounds, pharmaceutical compositions containing them and their use in therapy

Also Published As

Publication number Publication date
NO307458B1 (no) 2000-04-10
DK0767783T3 (da) 1999-05-25
FI115135B (fi) 2005-03-15
TW442451B (en) 2001-06-23
ATE169905T1 (de) 1998-09-15
JP3920916B2 (ja) 2007-05-30
NZ287291A (en) 1998-10-28
IL114185A (en) 1999-07-14
WO1995035279A1 (en) 1995-12-28
HU9603540D0 (en) 1997-02-28
DE69504198T2 (de) 1999-04-29
CA2193348C (en) 1999-08-24
NO965469L (no) 1997-02-19
AU2596195A (en) 1996-01-15
MX9606654A (es) 1997-12-31
CA2193348A1 (en) 1995-12-28
US5597845A (en) 1997-01-28
JPH10501551A (ja) 1998-02-10
CN1083429C (zh) 2002-04-24
EP0767783A1 (en) 1997-04-16
IL114185A0 (cg-RX-API-DMAC7.html) 1995-10-31
ZA954947B (en) 1996-01-31
ES2121389T3 (es) 1998-11-16
AU691619B2 (en) 1998-05-21
EP0767783B1 (en) 1998-08-19
CN1155883A (zh) 1997-07-30
NO965469D0 (no) 1996-12-19
FI965097L (fi) 1996-12-18
HUT75965A (en) 1997-05-28
FI965097A0 (fi) 1996-12-18
DE69504198D1 (de) 1998-09-24

Similar Documents

Publication Publication Date Title
KR100414321B1 (ko) 타치키닌수용체길항활성을갖는신규한치환된피페라진유도체
NZ219186A (en) Renin inhibitors: 5 amino-4-hydroxyvaleryl sulphur substituted derivatives
EP1717226B1 (en) 2,7-substituted 5-amino-4-hydroxy-8-(1h-indol-5-yl)-octan amide derivatives as renin inhibitors for the treatment of hypertension
KR100371981B1 (ko) 치환된알킬디아민유도체,이의제조방법및이를포함하는약제학적조성물
MC2107A1 (fr) Derives d'acides amines
CN1067068C (zh) 用作速激肽受体拮抗剂的杂环取代的哌嗪酮衍生物
JP4132671B2 (ja) タキキニン受容体アンタゴニストとしてのカルボキシ置換カルボキサミド誘導体

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20060130

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20060130